As a member of the collaborative, Cape Cod Hospital will implement recommendations to meet Boston-based Dana-Farber Cancer Institute’s clinical standards and have access to such services such as on-site speciality second opinion clinics, clinical trials and tumor board conferences.
“Providing the best quality care close to our patients’ homes, families and support systems is at the core of our mission at Cape Cod Healthcare,” said Michael Lauf, president and CEO of Cape Cod Healthcare. “This new affiliation with one of the premier cancer care and research institutions in the world means that people in our community now have access to the latest and best treatment options for a wide spectrum of cancers.”
More articles on healthcare transactions:
Dignity Health, CHI merge into $29B system
HCA completes $1.5B acquisition of Mission Health
Tenet sells 3 hospitals, exits Chicago market
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
